Hubbard Radio Washington DC, LLC. All rights reserved. This website is not intended for users located within the European Economic Area.
BETHESDA, Md. (AP) _ Northwest Biotherapeutics Inc. (NWBO) on Friday reported a loss of $194.1 million in its third quarter.
The Bethesda, Maryland-based company said it had a loss of 26 cents per share. Losses, adjusted for non-recurring costs and to extinguish debt, were 7 cents per share.
The cancer drug developer posted revenue of $216,000 in the period.
The company’s shares closed at $1.32. A year ago, they were trading at 21 cents.
Insight by Apptio: Learn how the SEC will utilize a new IT cost manager to review and analyze the agency’s spending on cloud services on a day-by-day basis in this free webinar.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NWBO at https://www.zacks.com/ap/NWBO
Copyright © 2021 . All rights reserved. This website is not intended for users located within the European Economic Area.